114 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
1 Recruiting Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Idelalisib;   Drug: Nab-paclitaxel;   Drug: mFOLFOX6
2 Unknown  Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Condition: Ductal Carcinoma In Situ
Interventions: Drug: Carboplatin i.d. Days 1 & 15;   Drug: Carboplatin i.d. Day 1; Normal Saline i.d. Day 15;   Drug: Normal Saline
3 Recruiting A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Dietary Supplement: Black cohosh
4 Recruiting Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 monotherapy;   Drug: tremelimumab+MEDI4736
5 Not yet recruiting Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 in combination with nab-paclitaxel and gemcitabine;   Drug: MEDI4736 in combination with AZD5069
6 Recruiting Effects of Diet and Exercise on Ductal Carcinoma in Situ
Conditions: Ductal Carcinoma In Situ;   Breast Cancer
Interventions: Behavioral: Active Comparator: Progressive Resistance Training (PRT) and a healthy diet;   Behavioral: Experimental: PRT and a healthy diet, plus weight loss
7 Recruiting A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Drug: Polyphenon E
8 Recruiting A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Behavioral: The risk assessment questionnaire;   Other: Blood specimens;   Other: tumor tissue samples will be requested
9 Not yet recruiting Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Drug: nab-paclitaxel;   Drug: gemcitabine
10 Recruiting Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)
Condition: Collecting Duct Carcinoma (Kidney)
Intervention: Drug: Bevacizumab
11 Recruiting Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Momelotinib;   Drug: Placebo to match momelotinib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
12 Unknown  Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Condition: Non-curative Resectable Bile Duct Carcinoma
Intervention: Drug: Temoporfin
13 Recruiting Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MMB;   Drug: Capecitabine;   Drug: Oxaliplatin
14 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy
15 Not yet recruiting Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Ductal Breast Carcinoma With Predominant Intraductal Component;   Lobular Breast Carcinoma in Situ;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Tubular Ductal Breast Carcinoma
Interventions: Radiation: accelerated partial breast irradiation;   Radiation: intensity-modulated radiation therapy;   Radiation: image-guided radiation therapy;   Procedure: therapeutic conventional surgery;   Other: questionnaire administration;   Other: laboratory biomarker analysis
16 Not yet recruiting Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
Conditions: Breast Neoplasm;   Carcinoma, Ductal, Breast;   Carcinoma, Intraductal, Noninfiltrating
Interventions: Procedure: Iron-tracer guided axillary ultrasound and biopsy;   Drug: Injection of iron-tracer
17 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
18 Not yet recruiting Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy
Conditions: Carcinoma, Ductal, Breast;   Menopausal
Intervention: Device: Cryoablation
19 Recruiting Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Condition: Carcinoma, Ductal, Breast
Interventions: Procedure: Biopsy before and after three weeks of study treatment;   Drug: Paclitaxel;   Drug: lapatinib;   Drug: trastuzumab
20 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years